Search by Drug Name or NDC

    NDC 72618-3000-02 NURTEC ODT 75 mg/1 Details

    NURTEC ODT 75 mg/1

    NURTEC ODT is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is RIMEGEPANT SULFATE.

    Product Information

    NDC 72618-3000
    Product ID 72618-3000_2324b31a-d161-463e-9c3a-b4b611fd3de1
    Associated GPIs 67701060707220
    GCN Sequence Number 080787
    GCN Sequence Number Description rimegepant sulfate TAB RAPDIS 75 MG ORAL
    HIC3 H3F
    HIC3 Description ANTIMIGRAINE PREPARATIONS
    GCN 47762
    HICL Sequence Number 046383
    HICL Sequence Number Description RIMEGEPANT SULFATE
    Brand/Generic Brand
    Proprietary Name NURTEC ODT
    Proprietary Name Suffix n/a
    Non-Proprietary Name rimegepant sulfate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, ORALLY DISINTEGRATING
    Route ORAL
    Active Ingredient Strength 75
    Active Ingredient Units mg/1
    Substance Name RIMEGEPANT SULFATE
    Labeler Name Pfizer Laboratories Div Pfizer Inc
    Pharmaceutical Class Calcitonin Gene-related Peptide Receptor Antagonist [EPC], Calcitonin Gene-related Peptide Receptor Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA212728
    Listing Certified Through 2024-12-31

    Package

    NDC 72618-3000-02 (72618300002)

    NDC Package Code 72618-3000-2
    Billing NDC 72618300002
    Package 1 BLISTER PACK in 1 CARTON (72618-3000-2) / 8 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
    Marketing Start Date 2020-03-05
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 119.632
    Pricing Unit EA
    Effective Date 2024-01-01
    NDC Description NURTEC ODT 75 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4
    Classification for Rate Setting B
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis